View in EDS HTML Full Text PDF Full Text

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.

Saved in:
Bibliographic Details
Title: Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
Authors: Galanis E; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Anderson SK; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Miller CR; Pathobiology and Translational Science Graduate Program, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina., Sarkaria JN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Jaeckle K; Department of Neurology, Mayo Clinic, Jacksonville, Minnesota., Buckner JC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ballman KV; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Moore DF Jr; Department of Internal Medicine, Cancer Center of Kansas, Wichita, Kansas., Nebozhyn M; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, Pennsylvania., Loboda A; Data Analysis, Informatics & Analysis Department, Merck Research Laboratories, Boston, Massachusetts., Schiff D; Neuro-Oncology Center, University of Virginia School of Medicine, Charlottesville, Virginia., Ahluwalia MS; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gerstner ER; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts., Lesser GJ; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Prados M; Department of Neurological Surgery, University of California San Francisco, San Francisco, California., Grossman SA; Department of Oncology, Medicine & Neurosurgery, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Cerhan J; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Giannini C; Department of Pathology, Mayo Clinic, Rochester, Minnesota., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Corporate Authors: Alliance for Clinical Trials in Oncology and ABTC
Source: Neuro-oncology [Neuro Oncol] 2018 Mar 27; Vol. 20 (4), pp. 546-556.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29016887
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Galanis+E%22">Galanis E</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Anderson+SK%22">Anderson SK</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Miller+CR%22">Miller CR</searchLink>; Pathobiology and Translational Science Graduate Program, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Sarkaria+JN%22">Sarkaria JN</searchLink>; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Jaeckle+K%22">Jaeckle K</searchLink>; Department of Neurology, Mayo Clinic, Jacksonville, Minnesota.<br /><searchLink fieldCode="AU" term="%22Buckner+JC%22">Buckner JC</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Ligon+KL%22">Ligon KL</searchLink>; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ballman+KV%22">Ballman KV</searchLink>; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Moore+DF+Jr%22">Moore DF Jr</searchLink>; Department of Internal Medicine, Cancer Center of Kansas, Wichita, Kansas.<br /><searchLink fieldCode="AU" term="%22Nebozhyn+M%22">Nebozhyn M</searchLink>; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Loboda+A%22">Loboda A</searchLink>; Data Analysis, Informatics & Analysis Department, Merck Research Laboratories, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Schiff+D%22">Schiff D</searchLink>; Neuro-Oncology Center, University of Virginia School of Medicine, Charlottesville, Virginia.<br /><searchLink fieldCode="AU" term="%22Ahluwalia+MS%22">Ahluwalia MS</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Lee+EQ%22">Lee EQ</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Gerstner+ER%22">Gerstner ER</searchLink>; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lesser+GJ%22">Lesser GJ</searchLink>; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina.<br /><searchLink fieldCode="AU" term="%22Prados+M%22">Prados M</searchLink>; Department of Neurological Surgery, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Grossman+SA%22">Grossman SA</searchLink>; Department of Oncology, Medicine & Neurosurgery, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Cerhan+J%22">Cerhan J</searchLink>; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Giannini+C%22">Giannini C</searchLink>; Department of Pathology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Wen+PY%22">Wen PY</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Alliance+for+Clinical+Trials+in+Oncology+and+ABTC%22">Alliance for Clinical Trials in Oncology and ABTC</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2018 Mar 27; Vol. 20 (4), pp. 546-556.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29016887
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/nox161
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 546
    Titles:
      – TitleFull: Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Galanis E
      – PersonEntity:
          Name:
            NameFull: Anderson SK
      – PersonEntity:
          Name:
            NameFull: Miller CR
      – PersonEntity:
          Name:
            NameFull: Sarkaria JN
      – PersonEntity:
          Name:
            NameFull: Jaeckle K
      – PersonEntity:
          Name:
            NameFull: Buckner JC
      – PersonEntity:
          Name:
            NameFull: Ligon KL
      – PersonEntity:
          Name:
            NameFull: Ballman KV
      – PersonEntity:
          Name:
            NameFull: Moore DF Jr
      – PersonEntity:
          Name:
            NameFull: Nebozhyn M
      – PersonEntity:
          Name:
            NameFull: Loboda A
      – PersonEntity:
          Name:
            NameFull: Schiff D
      – PersonEntity:
          Name:
            NameFull: Ahluwalia MS
      – PersonEntity:
          Name:
            NameFull: Lee EQ
      – PersonEntity:
          Name:
            NameFull: Gerstner ER
      – PersonEntity:
          Name:
            NameFull: Lesser GJ
      – PersonEntity:
          Name:
            NameFull: Prados M
      – PersonEntity:
          Name:
            NameFull: Grossman SA
      – PersonEntity:
          Name:
            NameFull: Cerhan J
      – PersonEntity:
          Name:
            NameFull: Giannini C
      – PersonEntity:
          Name:
            NameFull: Wen PY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 03
              Text: 2018 Mar 27
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1